aTYR PHARMA INC 10-Q filing
Filed 2025-11-06 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-269587
- Form type
- 10-Q
- CIK
- 0001339970
- Primary document
- https://www.sec.gov/Archives/edgar/data/1339970/000119312525269587/atyr-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for aTYR PHARMA INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $190,000 | - | - |
| Operating Income | $-62.8M | - | - |
| Net Income | $-60.2M | - | - |
| Eps Basic | -0.66 | - | - |
| Eps Diluted | -0.66 | - | - |
| Cash And Equivalents | $6.2M | - | - |
| Total Assets | $106.7M | - | - |
| Shareholders Equity | $80.2M | - | - |
| Operating Cash Flow | $-49.8M | - | - |
| Capital Expenditures | $46,000 | - | - |